✦ LIBER ✦

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

✍ Scribed by Richard G. Moore; Amy K. Brown; M. Craig Miller; Donna Badgwell; Zhen Lu; W. Jeffrey Allard; C.O. Granai; Robert C. Bast Jr; Karen Lu

Book ID: 113961587
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 144 KB
Volume: 110
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2008.04.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The utility of serum human epididymis pr

The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass

✍ Martina Montagnana; Giuseppe Lippi; Orazio Ruzzenente; Valentina Bresciani; Elis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract __Aim__: Although CA125 is the most widely used cancer marker in the diagnostic approach of pelvic masses in women, its clinical usefulness is limited because it lacks expression of the antigen in the early stages of disease. The human epididymis protein 4 (HE4) is frequently over‐expre

Cytopathological observations in a 27-ye

Cytopathological observations in a 27-year-old female patient with endometrioid adenocarcinoma arising in the lower uterine segment of the uterus

✍ Kazuyoshi Masuda; Chikao Yutani; Kazuhiko Akutagawa; Suguru Yamamoto; Hatsue Ish 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

The determination of the malignancy of an endometrioid adenocarcinoma arising in the lower uterine segment (LUS) is difficult because of the high degree of differentiation of adenocarcinoma. The cytopathological and immunohistochemical features of endometrioid adenocarcinoma arising in the LUS of a

Antigen CA125 in tumor tissue and serum

Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary

✍ T.S. Maughan; R.G. Fish; M. Shelley; B. Jasani; G.T. Williams; M. Adams 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Serum CCL5 levels might be utilized as a

Serum CCL5 levels might be utilized as a predictive marker of tumor behavior and prognosis in patients with gastric adenocarcinoma

✍ Sima Ali Reza; Rafatpanah Houshang; Sima Hamid Reza; Hosseinnezhad Hanieh; Ghaff 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Increased levels of serum pentraxin 3, a

Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease

✍ Ivana Hollan; Barbara Bottazzi; Ivan Cuccovillo; Øystein T. Førre; Knut Mikkelse 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 143 KB 👁 2 views

## Abstract ## Objective Pentraxin 3 (PTX3), a key component of innate immunity, is a strong marker of disease severity in coronary artery disease (CAD). The aim of this study was to compare levels of serum PTX3 in CAD patients with and without inflammatory rheumatic disease (IRD) and in healthy c

The use of multiple novel tumor biomarke

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

✍ Richard G. Moore; Amy K. Brown; M. Craig Miller; Steven Skates; W. Jeffrey Allar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 152 KB